Concepedia

Ashley Centner

AC

Statistics

Publications

4

Citations

58

H-Index

4

Active since

2020

Affiliations

Binghamton University(Current)

Barrow Neurological Institute

Ashley Centner is an author at Binghamton University specializing in neuropharmacology, neurology, and medicine.

Top concepts

MedicineNeurologyNeuropharmacologyNeurosciencePhysiologyPharmacologyNeurophysiologyPharmacotherapyDopamine ResearchAging

Publications per year

2020–2022

4

Publications

4

Genetic suppression of the dopamine D3 receptor in striatal D1 cells reduces the development of L-DOPA-induced dyskinesia

Kathryn Lanza, Ashley Centner, Michael Coyle et al. · Experimental Neurology · 2020 · 20 citations

Genetic Suppression, Developmental Biology, Dopamine D3 Receptor +7

Modulation of nigral dopamine signaling mitigates parkinsonian signs of aging: evidence from intervention with calorie restriction or inhibition of dopamine uptake

Michael F. Salvatore, Ella A. Kasanga, D. Parker Kelley et al. · GeroScience · 2022 · 14 citations · Full text

Energy Homeostasis, Aging, Longevity +10

The effects of Vilazodone, YL-0919 and Vortioxetine in hemiparkinsonian rats

Samantha K. Smith, Jordan Sergio, Michael Coyle et al. · Psychopharmacology · 2022 · 12 citations

Hemiparkinsonian Rats, Neurophysiology, Neuroanatomy +10

The multimodal serotonin compound Vilazodone alone, but not combined with the glutamate antagonist Amantadine, reduces l-DOPA-induced dyskinesia in hemiparkinsonian rats

Sophie R. Cohen, Michelle L. Terry, Michael Coyle et al. · Pharmacology Biochemistry and Behavior · 2022 · 12 citations

Hemiparkinsonian Rats, Glutamate Antagonist Amantadine, Neurophysiology +11

1–4 of 4